Table 2 The perioperative and postoperative outcomes
|  | Novel technique (Anatolian Neobladder) (n = 36) | Standard technique (Studer neobladder) (n = 16) | p |
|---|---|---|---|
Bleeding (ml) | 550 (350–1700) | 580 (300–1800) | 0.22 |
Operation time (h) | 5.5 (4–6.5) | 5.6 (4–7) | < 0.001 |
Hospitalization time (day) | 7.3 (6–20) | 7.3 (5–14) | 0.80 |
Early postoperative complications | 12 (33.3%) | 5 (31.2%) | 0.55 |
 -Urinary infection (Grade 2a) | 5 (13.8%) | 2 (12.5%) |  |
 -Paralytic ileus (Grade 2a) | 3 (8.3%) | 1 (6.2%) |  |
 -Skin infection (Grade 2a) | 4 (11.1%) | 2 (12.5%) |  |
Late postoperative complications | 6 (16.6%) | 3 (18.7%) | 0.65 |
 -Urinary infection | 3 (8.3%) | 1 (6.2%) |  |
 -Incisional hernia | 1 (2.7%) | – |  |
 -Urethro-neobladder stenosis | 1 (2.7%) | 1 (6.2%) |  |
 -Uretero-neobladder stenosis | 1 (2.7%) | 1 (6.2%) |  |
Survival time (months) (95%CI) | 71.6 (62.6–80.6) | 69.1 (53.9–84.1) | 0.72 |
Perioperative admission rate | 27.7% | 25.0% | 0.84 |
Postmictuonal residual urine (mL) 2. month | 34.7 | 34.4 | 0.80 |
Postoperative ICIQ-SF score | 2.7 (0–21) | 2.6 (0–21) | 0.72 |
Continence improved | |||
 -Daytime continence | 32/36 (88.8%) | 14/16 (87.5%) | 0.89 |
 -Nighttime continence | 20/36 (55.5%) | 9/16 (56.2%) | 0.96 |